Association of angiotensin-converting enzyme and angiotensin-converting enzyme-2 gene polymorphisms with essential hypertension in the population of Odisha, India

Annals of Human Biology

Volumn 41, Issue 2, 2014, Pages 145-152

  Patnaik, Manisha ^a   Pati, Pallabi ^a   Swain, Surendra N ^b   Mohapatra, Manoj K ^c   Dwibedi, Bhagirathi ^a   Kar, Shantanu K ^a   Ranjit, Manoranjan ^a  

^a REGIONAL MEDICAL RESEARCH CENTRE ICMR   (India)

^b Capital Hospital   (India)

^c VSS Medical College & Hospital   (India)

Author keywords

ACE; ACE2; Gene polymorphism; Hypertension; Risk factors

Indexed keywords

ALCOHOL; DISEASE; ENZYME; FOOD; GENETIC ANALYSIS; GENOTYPE; HEALTH RISK; HYPERTENSION; MALE; RISK FACTOR; TOBACCO;

INDIA; ODISHA;

ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ARTICLE; BLOOD PRESSURE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; HYPERTENSION; INDEL MUTATION; INDIA; MALE; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ALCOHOL DRINKING; ALLELES; BLOOD PRESSURE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; INDEL MUTATION; INDIA; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84893955875     PISSN: 03014460     EISSN: 14645033     Source Type: Journal    
DOI: 10.3109/03014460.2013.837195     Document Type: Article

References (41)

1. Bachmann J, Feldmer M, Ganten U, Stock G, Ganten D. 1991. Sexual dimorphism of blood pressure: possible role of the renin-angiotensin system. J Steroid Biochem Mol Biol 40:511-515.
2. Barley J, Blackwood A, Carter ND, Crews DE, Cruickshank JK, Jeffery S, Ogunlesi AO, Sagnella GA. 1994. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens 12:955-957.
3. Beilin LJ, Puddey IB, Burke V. 1996. Alcohol and hypertension-kill or cure? J Hum Hypertens 10:S1-S5.
4. Bhavani BA, Padma T, Sastry BKS, Reddy NK. 2004. Gender specific association of insertion/deletion polymorphism of the human angio-tensin converting enzyme gene with essential hypertension. Int J Hum Genet 4:207-213.
5. Chen Q, Tang X, Yu CQ, Chen DF, Tian J, Cao Y, Fan WY, et al. 2010. Correlation of angiotensin-converting enzyme 2 gene polymorphism with antihypertensive effects of benazepril. Beijing Da Xue Xue Bao 42:293-298.
6. Chiang FT, Chern TH, Lai ZP, Tseng CD, Hsu KL, Lo HM, Tseng YZ. 1996. Age-and gender-dependent association of the angiotensin-converting enzyme gene with essential hypertension in a Chinese population. J Hum Hypertens 10:823-826.
7. Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo JJ, Jones D, et al. 2003. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560-2572.
8. Choudhury I, Jothimalar R, Patra AK. 2012. Angiotensin converting enzyme gene polymorphism and its association with hypertension in south indian population. Ind J Clin Biochem 27:265-269.
9. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, et al. 2002. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417:822-828.
10. Duru K, Farrow S, Wang JM, Lockette W, Kurtz T. 1994. Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens 7:759-762.
11. Fan X, Wang Y, Sun K, Zhang W, Yang X, Wang S, Zhen Y, et al. 2007. Polymorphisms of ACE2 Gene are associated with essential hypertension and antihypertensive effects of captopril in women. Clin Pharmacol Ther 82:187-196.
12. Fan X-h, Wang Y-b, Wang H, Sun K, Zhang W-l, Song X-d, Cheng J-z, et al. 2009. Polymorphisms of angiotensin-converting enzyme (ACE) and ACE2 are not associated with orthostatic blood pressure dysregulation in hypertensive patients. Acta Pharmacol Sin 30: 1237-1244.
13. Gupta S, Agrawal BK, Goel RK, Sehajpal PK. 2009. Angiotensin-converting enzyme gene polymorphism in hypertensive rural population of Haryana, India. J Emerg Trauma Shock 2:150-154.
14. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CJW, Wat GCM. 1993. The angiotensin-converting enzyme gene and predisposition to high blood pressure. Hypertension 21:455-460.
15. Ismail M, Akhter N, Nasir M, Firesat S, Yub Q, Khaliq S. 2004. Association between the angiotensin-converting enzyme gene insertion/deletion polymorphism and essential hypertension in young Pakistani patients. J Biochem Mol Biol 37:552-555.
16. Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME. 2005. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens 23:463-473.
17. Lifton RP, Gharavi AG, Geller DS. 2001. Molecular mechanisms of human hypertension. Cell 104:545-556.
18. Mattei MG, Hubert C, Alhenc-Gelas F, Roeckel N, Corvol P, Soubrier F. 1989. Angiotensin I converting enzyme gene is on chromosome 17. Cytogenet Cell Genet 51:1041-1045.
19. Morshed M, Khan H, Akhteruzzaman S. 2002. Association between angiotensin I-converting enzyme gene polymorphism and hypertension in selected individuals of the Bangladeshi population. J Biochem Mol Biol 35:251-254.
20. Nakano Y, Oshima T, Hiraga H, Matsuura H, Kajiyama G, Kambe M. 1998. DD genotype of the angiotensin I-converting enzyme gene is a risk factor for early onset of essential hypertension in Japanese patients. J Lab Clin Med 131:502-506.
21. Nakayama T, Kuroi N, Sano M, Tabara Y, Katsuya T, Ogihara T, Makita Y, et al. 2006. Mutation of the follicle-stimulating hormone receptor gene 5-untranslated region associated with female hypertension. Hypertension 48:512-518.
22. National Cholesterol Education Program. (Adult Treatment Panel-III). 2002. Third report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Circulation 106:3143-3421.
23. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D. 1998. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97:1766-1772.
24. Patkar S, Charita BH, Ramesh C, Padma T. 2009. High risk of essential hypertension in males with intron 4 VNTR polymorphism of eNOS gene. Indian J Hum Genet 15:49-53.
25. Polimanti R, Piacentini S, Lazzarin N, Re MA, Manfellotto D, Fuciarelli M. 2011. Glutathione S-transferase variants as risk factor for essential hypertension in Italian patients. Mol Cell Biochem 357: 227-233.
26. Ramachandran V, Ismail P, Stanslas J, Shamsudin N, Moin S, Jas RM. 2008. Association of insertion/deletion polymorphism of angiotensin converting enzyme gene with essential hypertension and type 2 diabetes mellitus in Malaysian patients. J Renin Angiotensin Aldosterone Syst 9:208-214.
27. Rana BK, Insel PA, Payne SH, Abel K, Beutler E, Ziegler MG, Schork NJ, O'Connor DT. 2007. Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension 49:96-106.
28. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346.
29. Sagnella GA, Rothwell MJ, Onipinla AK, Wicks PD, Cook DG, Cappuccio FP. 1999. A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism, relationships with gender, hypertension and impaired glucose metabolism. J Hypertens 17:657-664.
30. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL. 1996. A Meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 94:708-712.
31. Sambrook J, Russell DW. 2001. Molecular cloning: a laboratory manual. Vol. 1. 3rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. p 6.4-6.11.
32. Sameer AS, Syeed N, Tak SA, Bashir S, Nissar S, Siddiqi MA. 2010. ACE I/D polymorphism in hypertensive patients of Kashmiri population. Cardiol Res 1:1-7.
33. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R. 1997. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 15:1579-1592.
34. Stanković A, Zivkovic M, Glisić S, Alavantić D. 2003. Angiotensin II type 1 receptor gene polymorphism and essential hypertension in Serbian population. Clin Chim Acta 327:181-185.
35. Suehiro T, Morita T, Inoue M, Kumon Y, Ikeda Y, Hashimoto K. 2004. Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion. Hum Genet 115:91-96.
36. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. 2000. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275:33238-33243.
37. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. 1992. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205.
38. Todkar SS, Gujarathi VV, Tapare VS. 2009. Period prevalence and sociodemographic factors of hypertension in rural Maharashtra: a cross-sectional study. Indian J Community Med 34:183-187.
39. Wang Z, Liu Y, Liu J, Liu K, Lou Y, Wen J, Niu Q, et al. 2010. E-selectin gene polymorphisms are associated with essential hypertension: a case-control pilot study in a Chinese population. BMC Med Genet 11: 127.
40. Wang Z, Liu Y, Liu J, Niu Q, Wen J, Wen S, Wu Z. 2013. A novel 5-uncoding region-1248 A4G variation of Mitofusin-2 gene is associated with hypertension in Chinese. Yonsei Med J 54: 603-608.
41. World Health Organization. 2000. WHO recommendations: obesity: preventing and managing the global epidemic. Technical Report Series no. 894. Geneva: World Health Organization.